BMS1026 Stewart Lecture 4 Sexually Transmitted Infections
Learning Outcomes
List the major sexually transmitted infections (STIs).
Understand their importance to public health.
Identify and describe the causative agents of STIs.
Outline clinical presentations of bacterial STIs.
Describe laboratory diagnosis of the different STIs.
Sexually Transmitted Infections (STIs)
Definition: A disease caused by a pathogen transmitted during sexual acts;
Sexually Transmitted Disease (STD): A term used interchangeably with STI.
Microorganisms involved: STIs comprise a diverse range of pathogens, categorized primarily into bacteria, viruses, fungi, and protozoa.
Major Pathogens Causing STIs
Bacteria
Gonorrhoea: Neisseria gonorrhoeae
Syphilis: Treponema pallidum
Chlamydia: Chlamydia trachomatis
Chancroid: Haemophilus ducreyi
Viruses
Genital Herpes: Herpes simplex virus type 2
Genital Warts: Papilloma virus
AIDS: Human Immunodeficiency virus (HIV)
Fungi
Candidiasis (Thrush): Candida albicans
Protozoa
Trichomoniasis: Trichomonas vaginalis
Public Health Importance of STIs
STIs are significant contributors to morbidity and mortality worldwide.
Syphilis leads to approximately 300,000 neonatal deaths annually.
HPV is linked to 250,000 cervical cancer deaths.
HIV/AIDS results in about 700,000 deaths each year.
Other consequences of STIs include:
Infertility
Heart disease
Blindness
General Characteristics of STIs
Infectious agents are not shed in large quantities but can be efficiently transmitted through person-to-person contact, particularly in moist genitourinary (GU) tracts.
Agents tend to be sensitive to environmental factors such as drying, light, and heat.
Symptoms are often absent or unclear, leading to many undetected cases of STIs.
Co-infections are common; one infection may be masked by another, leading to delayed treatment.
Classification of STIs
STIs causing discharge:
Gonorrhoea
Chlamydial infection
Trichomoniasis
Candidal infection
Bacterial vaginosis
STIs causing ulceration:
Syphilis
Chancroid
Epidemiology of STIs
STIs often have higher incidence rates in specific demographics, particularly young people.
Statistical representation of STI diagnoses by age and gender shows significant trends in incidence rates.
Gonorrhoea: Neisseria gonorrhoeae
Overview: Widespread infection; diagnosed with around 70,000 cases in the UK alone in 2019.
Transmission: Occurs via person-to-person contact; primarily through mucous membranes of the genitourinary tract.
Clinical Presentation
Uncomplicated Infection:
Men: Painful urethra infection; primary site of infection is the urethra, with the rectum and pharynx as potential sites.
Women: Often mild symptoms leading to unnoticed infections; cervix is the primary site; may include vaginitis.
Complicated Infection:
Men: Can progress to prostatitis and epididymitis.
Women: Can progress to salpingitis and pelvic inflammatory disease (PID).
Pathogenesis
N. gonorrhoeae adheres to columnar epithelial cells using pili, invades epithelial cells, and may trigger inflammation leading to mucosal damage.
Diagnosis and Treatment
Diagnosis: Microscopy of urethral smears for intracellular diplococci; culture on selective media.
Treatment: A single dose of penicillin can cure but resistance is increasing; alternatives include ciprofloxacin, cefixime, and ceftriaxone; doxycycline for concurrent chlamydia treatment is prudent.
Antibiotic Resistance: Growing concerns regarding reduced susceptibility requiring combination treatments (e.g., injectable ceftriaxone and oral azithromycin).
Chlamydia: Chlamydia trachomatis
Characteristics: Obligately intracellular parasite, cannot be cultured on agar; has two forms:
Elementary bodies (extracellular)
Reticulate particles (intracellular)
Clinical Presentation
Women: Mucopurulent cervicitis, pelvic inflammatory disease (major infertility cause).
Men: Often asymptomatic; may cause non-gonococcal urethritis with discharge.
Diagnosis and Treatment
Diagnosis Options:
Growth in tissue culture (difficult, variable sensitivity)
Immunofluorescence (highly sensitive)
Immunoassays (applicable for larger specimens)
Molecular techniques (PCR for high sensitivity, costly)
Treatment: Tetracycline or doxycycline.
Epidemiology: Common in young populations; overall incidence remains high but stabilized since 2006.
Syphilis: Treponema pallidum
Infection Phases:
Primary: painless ulcer
Secondary: systemic illness with fever
Latent: no symptoms
Tertiary: cardiovascular or neurological issues
Transmission occurs via broken skin.
Diagnosis and Treatment
Diagnosis through dark-ground microscopy; detection of antibodies is preferred.
Treatment: Penicillin.
Epidemiology
Rising cases observed since the 1990s, particularly among males and men who have sex with men.
Chancroid: Haemophilus ducreyi
Overview: Common in the Tropics; shallow painful ulcers, potential lymphadenopathy.
Diagnosis: Based on clinical presentation, microscopy, and exclusion of syphilis.
Treatment: Erythromycin and ciprofloxacin are effective, though resistance can occur.